SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis

Edinson Dante Meregildo-Rodriguez; Martha Genara Asmat-Rubio; Gustavo Adolfo Vásquez-Tirado

doi:10.3389/fendo.2023.1307715

SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis

Edinson Dante Meregildo-Rodriguez
, Martha Genara Asmat-Rubio
, Gustavo Adolfo Vásquez-Tirado

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Original language	English
Article number	1307715
Journal	Frontiers in Endocrinology
Volume	14
DOIs	https://doi.org/10.3389/fendo.2023.1307715
State	Published - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3389/fendo.2023.1307715

Cite this

Meregildo-Rodriguez, E. D., Asmat-Rubio, M. G., & Vásquez-Tirado, G. A. (2023). SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis. Frontiers in Endocrinology, 14, Article 1307715. https://doi.org/10.3389/fendo.2023.1307715

@article{e5a3bcb3326e419aa82efa83a13de006,

title = "SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis",

keywords = "SGLT2 inhibitors, acute kidney injury, contrast-induced nephropathy, meta-analysis, sodium-glucose transporter 2 inhibitors, systematic review",

author = "Meregildo-Rodriguez, \{Edinson Dante\} and Asmat-Rubio, \{Martha Genara\} and V{\'a}squez-Tirado, \{Gustavo Adolfo\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 Meregildo-Rodriguez, Asmat-Rubio and V{\'a}squez-Tirado.",

year = "2023",

month = jan,

day = "1",

doi = "10.3389/fendo.2023.1307715",

language = "English",

volume = "14",

journal = "Frontiers in Endocrinology",

issn = "1664-2392",

publisher = "Frontiers Media S.A.",

}

SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis. / Meregildo-Rodriguez, Edinson Dante; Asmat-Rubio, Martha Genara; Vásquez-Tirado, Gustavo Adolfo.
In: Frontiers in Endocrinology, Vol. 14, 1307715, 01.01.2023.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions

T2 - systematic review and meta-analysis

AU - Meregildo-Rodriguez, Edinson Dante

AU - Asmat-Rubio, Martha Genara

AU - Vásquez-Tirado, Gustavo Adolfo

PY - 2023/1/1

Y1 - 2023/1/1

KW - SGLT2 inhibitors

KW - acute kidney injury

KW - contrast-induced nephropathy

KW - meta-analysis

KW - sodium-glucose transporter 2 inhibitors

KW - systematic review

UR - https://www.scopus.com/pages/publications/85181440804

U2 - 10.3389/fendo.2023.1307715

DO - 10.3389/fendo.2023.1307715

M3 - Review article

AN - SCOPUS:85181440804

SN - 1664-2392

VL - 14

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

M1 - 1307715

ER -

SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this